RxDoctor Payments Data

Paul Weiss, MD

Psychiatry · Taunton, MANPI 1205989555

Payments from drug & device makers

$525in general payments, 2019–2025

Across 29 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$272
  • Otsuka America Pharmaceutical, Inc.$69
  • Sunovion Pharmaceuticals Inc.$58
  • Johnson & Johnson$57
  • E.r. Squibb & Sons, L.L.C.$38
  • Ironshore Pharmaceuticals Inc.$19
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$51298%
  • Education$132%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$525 in reported general payments places this provider in the 75th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts

Medicare billing

Part B allowed, 2024
$36,321
Medicare patients
154
Services billed
293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate67$173,799
Invega TrinzaPaliperidone Palmitate14$133,085
Risperdal ConstaRisperidone Microspheres43$53,403
Abilify MaintenaAripiprazole13$36,204
Clozapine476$29,592
CaplytaLumateperone Tosylate15$25,626
Aripiprazole161$17,477
Paliperidone ErPaliperidone71$6,589
Olanzapine272$4,841
Chlorpromazine Hcl56$4,025
Benztropine Mesylate292$3,621
Clonazepam337$3,204
Quetiapine Fumarate191$3,128
Perphenazine93$3,098
Risperidone261$2,975

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta$57$360,287124 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$69$36,20413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,431 psychiatry providers in Massachusetts.

Other psychiatry in Taunton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →